Skip to main content
OpenTrials

Clinical trial condition

Episodic Migraine

Explore clinical trials studying Episodic Migraine. Study availability and eligibility vary by location and protocol.

48 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Episodic Migraine trial results

Active, not recruiting

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

NCT03432286

Conditions
Episodic Migraine, Headache, Neurologic Manifestations, +3 more
Locations
  • Rehabilitation & Neurological Services Huntsville, Alabama, United States
  • 21st Century Neurology, a Division of Xenoscience, Inc. Phoenix, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
View all 73 locations
View Trial Details
Completed

A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

NCT04686136

Conditions
Chronic Migraine, Episodic Migraine
Locations
  • Duplicate_Barrow Neurological Institute /ID# 228217 Phoenix, Arizona, United States
  • California Headache and Balance Center /ID# 226241 Fresno, California, United States
  • Duplicate_Pharmacology Research Institute (PRI) - Los Alamitos (Wake) /ID# 226404 Los Alamitos, California, United States
  • Pharmacology Research Institute (PRI) - Newport Beach (Wake) /ID# 226389 Newport Beach, California, United States
View all 116 locations
View Trial Details
Completed

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

NCT05207865

Conditions
Brain Diseases, Central Nervous System Diseases, Ear Diseases, +17 more
Locations
  • Elite Clinical Studies, LLC Phoenix, Arizona, United States
  • Advanced Investigative Medicine, Inc. Hawthorne, California, United States
  • Velocity Clinical Research - North Hollywood North Hollywood, California, United States
  • Chase Medical Research, LLC Waterbury, Connecticut, United States
View all 19 locations
View Trial Details
Completed

A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine

NCT04437433

Conditions
Chronic Migraine, Episodic Migraine
Locations
  • Takanoko Hospital /ID# 232723 Matsuyama, Ehime, Japan
  • Fukuiken Saiseikai Hospital /ID# 232988 Fukui-shi, Fukui, Japan
  • Duplicate_Higashi Sapporo Neurology and Neurosurgery Clinic /ID# 232710 Sapporo, Hokkaido, Japan
  • Konan Medical Center /ID# 232922 Kobe, Hyōgo, Japan
View all 24 locations
View Trial Details
Completed

Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

NCT05264129

Conditions
Episodic Migraine
Locations
  • Achieve Clinical Research, LLC /ID# 244912 Birmingham, Alabama, United States
  • Xenoscience, Inc /ID# 243506 Phoenix, Arizona, United States
  • Excell Research, Inc /ID# 242590 Oceanside, California, United States
  • Neurological Research Institute /ID# 244161 Santa Monica, California, United States
View all 37 locations
View Trial Details

Related conditions